Back to Agendas
Session 9BC: Non Clinical and Clinical Track Combination: Thrombocytopenia – OSWG
Session Chair(s)
Scott Henry, PhD
Vice President, Nonclinical Development
Ionis Pharmaceuticals, Inc., United States
Robert T. Dorsam, PhD
Associate Director, Pharmacology/Toxicology, Office of Generic Drugs, CDER
FDA, United States
Speaker(s)
Progress in Understanding the Mechanism of ASO-Mediated Platelet Decrease in Non-human Primates
Padma Narayanan
Ionis Pharmaceuticals, Inc., United States
Executive Director, Toxicology
Speaker Invited
United States
Panel Discussion
All Session Speakers, United States
Have an account?